Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy

The prevalence of diabetes is at pandemic levels in today’s society. Microvascular complications in organs including the eye are commonly observed in human diabetic subjects. Diabetic retinopathy (DR) is a prominent microvascular complication observed in many diabetics and is particularly debilitati...

Full description

Bibliographic Details
Main Authors:	Lakshini Y. Herat, Vance B. Matthews, P. Elizabeth Rakoczy, Revathy Carnagarin, Markus Schlaich
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2018/9254126

Similar Items

Sympathetic stimulation with norepinephrine may come at a cost
by: Lakshini Y Herat, et al.
Published: (2019-01-01)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
by: Revathy Carnagarin, et al.
Published: (2019-01-01)

The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Sympathetic Nervous Activity
by: Ningning Wan, et al.
Published: (2018-07-01)

Current Knowledge of IL-6 Cytokine Family Members in Acute and Chronic Kidney Disease
by: Aaron L. Magno, et al.
Published: (2019-03-01)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
by: Revathy Carnagarin, et al.
Published: (2021-04-01)

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy – a perspective
by: Márcio Kiuchi, et al.
Published: (2019-12-01)

Sodium glucose cotransporter (SGLT)-2 inhibitors alleviate the renal stress responsible for sympathetic activation
by: Motoaki Sano
Published: (2020-07-01)

New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure—Targeting the Sympathetic Nervous System
by: Márcio Galindo Kiuchi, et al.
Published: (2019-05-01)

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
by: Márcio Galindo Kiuchi, et al.
Published: (2020-01-01)

Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy
by: Eun Hyung Cho, et al.
Published: (2018-01-01)

Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension
by: Yusuke Sata, et al.
Published: (2018-03-01)

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
by: Alicia A. Thorp, et al.
Published: (2015-01-01)

The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice
by: Lakshini Herat, et al.
Published: (2017-04-01)

The Schlager mouse as a model of altered retinal phenotype
by: Lakshini Y Herat, et al.
Published: (2020-01-01)

Renal glucose handling in diabetes and sodium glucose cotransporter 2 inhibition
by: Resham Raj Poudel
Published: (2013-01-01)

Genetic variability in sodium-glucose cotransporter 2 influences glycemic control and risk for diabetic retinopathy in type 2 diabetes patients
by: Klen Jasna, et al.
Published: (2020-01-01)

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
by: Santos Cavaiola T, et al.
Published: (2018-04-01)

Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance
by: Álvaro García-Ropero, et al.
Published: (2019-07-01)

Sodium–glucose cotransporters: Functional properties and pharmaceutical potential
by: Ryuhei Sano, et al.
Published: (2020-07-01)

Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
by: M. Arow, et al.
Published: (2020-01-01)

Sodium-glucose Cotransporter-2 Induced Diabetic Ketoacidosis with Minimal Hyperglycemia
by: D. Taylor Gammons
Published: (2018-01-01)

Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
by: Janis M. Nolde, et al.
Published: (2021-08-01)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
by: Yoko Takatsuna, et al.
Published: (2020-01-01)

Sodium-Glucose Cotransporter Inhibition Prevents Oxidative Stress in the Kidney of Diabetic Rats
by: Horacio Osorio, et al.
Published: (2012-01-01)

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
by: Ahmadieh H, et al.
Published: (2017-05-01)

Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients
by: Boyang Xiang, et al.
Published: (2021-04-01)

Update on the impact of sodium-glucose cotransporter inhibitors in diabetic kidney disease progression
by: Ana Carolina Cruz Afonso Romano
Published: (2021)

GI inflammation Increases Sodium-Glucose Cotransporter Sglt1
by: Jiyoung Park, et al.
Published: (2019-05-01)

Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
by: Fan Yang, et al.
Published: (2020-12-01)

SGLT2 Inhibitor-Induced Sympathoexcitation in White Adipose Tissue: A Novel Mechanism for Beiging
by: Jennifer R. Matthews, et al.
Published: (2020-11-01)

Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study.
by: Yoo-Ri Chung, et al.
Published: (2019-01-01)

Insulin enhances renal glucose excretion: relation to insulin sensitivity and sodium-glucose cotransport
by: Ele Ferrannini, et al.
Published: (2020-04-01)

Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
by: Daniel A. Kelmenson MD, et al.
Published: (2017-06-01)

Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives
by: Mathew John, et al.
Published: (2016-01-01)

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
by: Kim Y, et al.
Published: (2012-08-01)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
by: Muhammad Shahzeb Khan, et al.
Published: (2019-11-01)

Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
by: Lu Chen, et al.
Published: (2020-09-01)

Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure
by: Reed JW
Published: (2016-10-01)

Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors
by: Hidekatsu Yanai, et al.
Published: (2021-04-01)